Details
| Stereochemistry | MIXED |
| Molecular Formula | 2C13H29N.C6H10O8 |
| Molecular Weight | 608.8909 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCCC(C)NCCC(C)C.CC(C)CCCC(C)NCCC(C)C.O[C@@H]([C@@H](O)[C@H](O)C(O)=O)[C@@H](O)C(O)=O
InChI
InChIKey=UJGUOLMDGMDNGF-IBGZLQDMSA-N
InChI=1S/2C13H29N.C6H10O8/c2*1-11(2)7-6-8-13(5)14-10-9-12(3)4;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2*11-14H,6-10H2,1-5H3;1-4,7-10H,(H,11,12)(H,13,14)/t;;1-,2+,3+,4-
| Molecular Formula | C6H10O8 |
| Molecular Weight | 210.1388 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C13H29N |
| Molecular Weight | 199.3761 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Octinum-D Approved UseAntispasmodic; for digestive, urinary tract and sphincter cramps, migraine headaches, urinary tract and hiccup, gastrointestinal tract equipment examination. For canker, cholecystitis, cholelithiasis diseases caused by abdominal pain, and the effect of atropine similar, but no other adverse reactions, dry mouth. |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 59.0 |
no | |||
Page: 60.0 |
no | |||
Page: 52.0 |
no | |||
Page: 58.0 |
no | |||
Page: 1.0 |
yes [IC50 0.5495 uM] |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 58.0 |
Sample Use Guides
In Vivo Use Guide
Sources: http://chemyq.com/En/xz/xz12/119073rdaqo.htm
Oral: Each compound drops 25 to 40 drops
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:44:14 GMT 2025
by
admin
on
Mon Mar 31 22:44:14 GMT 2025
|
| Record UNII |
L9S34T2T2J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB03482MIG
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY | |||
|
93918-97-9
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY | |||
|
299-979-7
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY | |||
|
44151233
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY | |||
|
100000085727
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY | |||
|
L9S34T2T2J
Created by
admin on Mon Mar 31 22:44:14 GMT 2025 , Edited by admin on Mon Mar 31 22:44:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|